FLU-M

Flu-M® [Influenza Vaccine (Split Viruses, Inactivated)]

 

Flu-M® [Influenza Vaccine (Split Viruses, Inactivated)] combines 7 antigens (surface and internal) of influenza virus subtype A (H1N1), subtype A (H3N2) and type B. A highly purified vaccine in phosphate buffered saline.

The main characteristics of the ingredients of the Flu-M vaccine and the quality indicator is its ability to develop an effective immune response against strains of great epidemiological importance circulated in the world.

During the technological production process, the optimal manufacturing conditions have been adapted to:

1) Maintain stable protective qualities of antigens necessary to guarantee the effective interaction of antigens and cells and preserve the so-called «confirmatory protective epitopes».

2) Manufacture a pharmaceutical product that meets all international requirements.Hemagglutinin protein is a key protective antigen. Hemagglutinin is an integral membrane protein with a tendency to aggregation. The composition of Flu-M contains a stabilizer that prevents the aggregation of Hemagglutinin and that it loses its antigenic qualities.

Highly purified low reactogenicity antigens are used to make Flu-M®. The vaccine has a relatively low level of adverse effects, its characteristics of immunobiological activity comply with international requirements for influenza vaccines and guarantee immunity against influenza after its application.

FINAL COMPOSITION Flu-M® [Influenza Vaccine (Split Viruses, Inactivated)]

Contenido

Contenido por una dosis

Función


Ingredientes activos
Hemaglutinina А
(H1N1)
15
mcg

Antígeno(ingrediente activo)

Hemaglutinina А
(H3N2)
15
mcg
Hemaglutinina tipo В 15
mcg

Sustancias auxiliares:
Tiomersal 50
mcg
Preservante
(multidosis)
 -  - Sin preservantes (una dosis)
Triton Х-100 No más de 100 µg Estabilizador
Tampón fosfato salino Hasta
0,5 ml
Diluyente

TOP